The Neurocognitive Effects of Total and Partial Sleep Deprivation in Younger Adults.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-40
SponsorÖrebro University, Sweden

About this trial

This study aims to examine how total and partial sleep deprivation affect brain function, cognitive performance, and biomarkers related to stress and inflammation in the same participants using a crossover design. The study will also compare the effects of total and partial sleep deprivation to determine whether these conditions affect the brain and body differently. The findings may improve our understanding of the consequences of sleep deprivation and help inform strategies to reduce its negative impact on health and society.

* How does total versus partial sleep deprivation affect brain activity during rest and cognitive tasks? * How does sleep deprivation affect functional connectivity between brain networks? * How does sleep deprivation affect working memory, attention, and executive control? * How does sleep deprivation affect biomarkers of stress and inflammation, such as cortisol? * Are changes in brain activity and connectivity associated with changes in cognitive performance and biological markers? * Can combining MRI-based and non-MRI-based measures provide a more complete picture of the effects of sleep deprivation?

Participants will complete three study conditions in a randomized order:

Total Sleep Deprivation (TSD): 28 to 32 hours of continuous wakefulness. Partial Sleep Deprivation (PSD): sleep restricted to 4 hours per night for two consecutive nights.

Normal Sleep (control condition): a night of habitual sleep without sleep restriction.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Signed informed consent prior to any study-related procedures.

Age 20 to 40 years.

Normal weight at screening, defined as a BMI between 18.5 and 24.9.

Willingness to comply with the study protocol.

Disqualifiers

Current diagnosis of a psychiatric or neurological disorder or syndrome.

Current diagnosis of another medical condition that limits study participation.

Diagnosed sleep disorder (e.g., insomnia).

Self-reported poor sleep quality (>5 on the PSQI).

Trial design

Design model

Crossover

Treatments tested in this trial

  • Total sleep deprivation

    Behavioral

    No sleep for 28-32 hours.

  • Partial sleep deprivation

    Behavioral

    Restriction to 4 hours sleep/night for two consecutive nights.

  • Normal sleep

    Behavioral

    Normal (7-9 hours) sleep, following normal patterns of wakeup and sleep onset.

Treatment groups

24 Participants
are divided into 3 treatment groups
Group A: Normal sleepOther 1 intervention
Group B: Total Sleep DeprivationOther 1 intervention
Group C: Partial Sleep DeprivationOther 1 intervention

Trial outcomes

Primary outcomes

1

Brain functional activity and connectivity (PVT)

Compare normal sleep to SD (total and partial)

Time frame
3 weeks

Secondary outcomes

1

Brain functional activity and connectivity (PVT) - SD

Compare total sleep deprivation and partial sleep deprivation.

Time frame
3 weeks
2

Brain functional activity and connectivity (NBACK)

Time frame
3 weeks
3

Brain functional activity and connectivity (MST)

Time frame
3 weeks
4

Brain functional activity and connectivity (SST)

Time frame
3 weeks

Other outcomes

1

Faecal samples for evaluation of gut microbiota composition

Time frame
1 day
2

Levels of neural function markers (e.g. S100B)

Time frame
3 weeks
3

Physical activity assessed using actigraphy

Time frame
3 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: